Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 March;58(1) > Panminerva Medica 2016 March;58(1):86-93

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

REVIEWS  


Panminerva Medica 2016 March;58(1):86-93

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Impact of metabolic comorbidities on outcomes of patients with acute pancreatitis: a scoping review

Rachel L. GOODGER, Varsha M. ASRANI, John A. WINDSOR, Maxim S. PETROV

Department of Surgery, University of Auckland, Auckland, New Zealand


PDF  


With the increasing prevalence of metabolic comorbidities, their impact on outcomes of patients with acute pancreatitis needs to be considered. Metabolic comorbidities, such as diabetes mellitus, obesity, and metabolic syndrome, have been shown to have a role to play in the course of disease. This scoping review aims to map published clinical studies that have investigated the impact of metabolic comorbidities on outcomes in patients with acute pancreatitis.

top of page

Publication History

Cite this article as

Corresponding author e-mail

max.petrov@gmail.com